Literature DB >> 3007925

Experimental diabetes mellitus impairs the function of the retinal pigmented epithelium.

L C MacGregor, F M Matschinsky.   

Abstract

The retinal pigmented epithelium (RPE), which influences the composition of the retinal extracellular fluid, is significantly affected in diabetes. Changes in RPE morphology, permeability, and electrophysiology in experimentally diabetic animals have been described. To facilitate the study of diabetes-related changes in RPE metabolism, we applied the techniques of quantitative histochemistry to pure samples of RPE and individual retinal layers from eyes of normal and alloxan-diabetic rabbits. Glucose within the RPE approximated serum levels in both normal and diabetic animals. Other changes in diabetics included increased sorbitol, decreased myo-inositol, elevated total Na, and loss of measurable Na+-K+-ATPase activity within the RPE. The altered ion metabolism was associated with a progressive decrease in the amplitude of the RPE-generated c-wave of the electroretinogram. The deterioration of the c-wave was arrested by treatment of the diabetic animals with either myo-inositol supplementation or with sorbinil, an inhibitor of aldose reduction. Diabetic alterations in the RPE might impair the ability of the tissue to maintain normal transport functions. The subsequently altered composition of the extracellular environment of the retina may play an important role in the pathogenesis of diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3007925     DOI: 10.1016/0026-0495(86)90184-8

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  19 in total

1.  Glucose-specific regulation of aldose reductase in capan-1 human pancreatic duct cells In vitro.

Authors:  J V Busik; S R Hootman; C A Greenidge; D N Henry
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

2.  RPE barrier breakdown in diabetic retinopathy: seeing is believing.

Authors:  Hui-Zhuo Xu; Zhiming Song; Shuhua Fu; Meili Zhu; Yun-Zheng Le
Journal:  J Ocul Biol Dis Infor       Date:  2011-12-31

3.  Significance of outer blood-retina barrier breakdown in diabetes and ischemia.

Authors:  Hui-Zhuo Xu; Yun-Zheng Le
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-05       Impact factor: 4.799

4.  Myo-inositol and prostaglandins reverse the glucose inhibition of neural tube fusion in cultured mouse embryos.

Authors:  L Baker; R Piddington; A Goldman; J Egler; J Moehring
Journal:  Diabetologia       Date:  1990-10       Impact factor: 10.122

5.  Mechanism of glucose-induced (Na+, K+)-ATPase inhibition in aortic wall of rabbits.

Authors:  D A Simmons; A I Winegrad
Journal:  Diabetologia       Date:  1989-07       Impact factor: 10.122

6.  Na,K-ATPase in diabetic rat small intestine. Changes at protein and mRNA levels and role of glucagon.

Authors:  K Barada; C Okolo; M Field; N Cortas
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

7.  Chronic exposure to high glucose decreases myo-inositol in cultured cerebral microvascular pericytes but not in endothelium.

Authors:  I Sussman; M P Carson; V Schultz; X P Wu; A L McCall; N B Ruderman; K Tornheim
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

8.  The fast oscillation of the EOG in diabetes with and without mild retinopathy.

Authors:  Marilyn E Schneck; Leslie Shupenko; Anthony J Adams
Journal:  Doc Ophthalmol       Date:  2007-10-25       Impact factor: 2.379

9.  Effects of aldose reductase inhibition with tolrestat on diabetic retinopathy in a six months double blind trial.

Authors:  J M van Gerven; J P Boot; H H Lemkes; J A van Best
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

10.  Exclusion of aldose reductase as a mediator of ERG deficits in a mouse model of diabetic eye disease.

Authors:  Ivy S Samuels; Chieh-Allen Lee; J Mark Petrash; Neal S Peachey; Timothy S Kern
Journal:  Vis Neurosci       Date:  2012-10-29       Impact factor: 3.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.